Shares of InterCure Ltd. (NASDAQ:INCR – Get Free Report) shot up 5.3% during mid-day trading on Tuesday. The stock traded as high as $3.70 and last traded at $3.8240. Approximately 14,263 shares traded hands during trading, an increase of 75% from the average daily volume of 8,153 shares. The stock had previously closed at $3.63.
Wall Street Analyst Weigh In
Separately, Weiss Ratings cut shares of InterCure from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.
Get Our Latest Stock Report on INCR
InterCure Stock Performance
The business has a 50-day moving average price of $4.79 and a 200 day moving average price of $4.58.
InterCure Company Profile
InterCure Ltd. (NASDAQ: INCR), also known as Canndoc, is an Israel-based cannabis company focused on the cultivation, production, distribution and sale of medical cannabis products. The company operates across the cannabis value chain, from growing and processing cannabis to supplying products through pharmacies and other regulated channels. InterCure offers cannabis flower, oils and other medical cannabis products under its own brands and through international brand partnerships. Its portfolio has included the Cookies brand through a strategic partnership, along with products marketed under the Canndoc name.
Further Reading
- Five stocks we like better than InterCure
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.
